Found: 95
Select item for more details and to access through your institution.
BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1632, doi. 10.1002/ajh.27359
- By:
- Publication type:
- Article
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65404-7
- By:
- Publication type:
- Article
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1814, doi. 10.1001/jama.2024.4783
- By:
- Publication type:
- Article
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1561, doi. 10.1007/s00277-024-05649-4
- By:
- Publication type:
- Article
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision‐making.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1523, doi. 10.1111/bjh.19200
- By:
- Publication type:
- Article
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle‐cell lymphoma and chronic lymphocytic leukaemia.
- Published in:
- Journal of Cellular & Molecular Medicine, 2023, v. 27, n. 20, p. 3053, doi. 10.1111/jcmm.17868
- By:
- Publication type:
- Article
Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6281, doi. 10.3390/jcm12196281
- By:
- Publication type:
- Article
Analogies between COVID-19 and Preeclampsia: Focus on Therapies.
- Published in:
- International Journal of Translational Medicine, 2023, v. 3, n. 2, p. 203, doi. 10.3390/ijtm3020015
- By:
- Publication type:
- Article
Single‐center study on SARS‐CoV‐2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9662, doi. 10.1002/cam4.5923
- By:
- Publication type:
- Article
Biosimilar erythropoiesis‐stimulating agents are an effective and safe option for the management of myelofibrosis‐related anemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 354, doi. 10.1111/ejh.13910
- By:
- Publication type:
- Article
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706).
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1201, doi. 10.1002/jha2.544
- By:
- Publication type:
- Article
Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/v14102207
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1075, doi. 10.1002/ajh.26556
- By:
- Publication type:
- Article
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. E296, doi. 10.1002/ajh.26618
- By:
- Publication type:
- Article
Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 12, p. 2377, doi. 10.3390/v13122377
- By:
- Publication type:
- Article
Molecular Pathogenesis of BCR-ABL -Negative Atypical Chronic Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.756348
- By:
- Publication type:
- Article
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4422, doi. 10.3390/cancers13174422
- By:
- Publication type:
- Article
Long‐term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 808, doi. 10.1111/ejh.13608
- By:
- Publication type:
- Article
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.668261
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic‐phase CML in clinical practice: 3‐year European SIMPLICITY data.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 82, doi. 10.1111/ejh.13524
- By:
- Publication type:
- Article
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)‐positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E319, doi. 10.1002/ajh.25967
- By:
- Publication type:
- Article
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3692, doi. 10.3390/jcm9113692
- By:
- Publication type:
- Article
Increased sFLT‐1/PlGF ratio in COVID‐19: A novel link to angiotensin II‐mediated endothelial dysfunction.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. E188, doi. 10.1002/ajh.25882
- By:
- Publication type:
- Article
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 1, p. 71, doi. 10.1002/ccr3.2531
- By:
- Publication type:
- Article
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL).
- Published in:
- 2019
- By:
- Publication type:
- case study
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.235
- By:
- Publication type:
- Article
Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S294, doi. 10.1016/j.clml.2019.07.243
- By:
- Publication type:
- Article
Deferasirox in the management of iron‐overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON‐M study).
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. e123, doi. 10.1111/bjh.15964
- By:
- Publication type:
- Article
Acute myeloid leukaemia niche regulates response to L‐asparaginase.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. 420, doi. 10.1111/bjh.15920
- By:
- Publication type:
- Article
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1589, doi. 10.1007/s00432-019-02894-3
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 46, doi. 10.1002/ajh.25306
- By:
- Publication type:
- Article
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0685-2
- By:
- Publication type:
- Article
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling.
- Published in:
- Cancers, 2018, v. 10, n. 12, p. 509, doi. 10.3390/cancers10120509
- By:
- Publication type:
- Article
An Observational Study of Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S229, doi. 10.1016/j.clml.2018.07.105
- By:
- Publication type:
- Article
Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 607, doi. 10.1002/ajh.25043
- By:
- Publication type:
- Article
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.
- Published in:
- Cancers, 2018, v. 10, n. 3, p. 62, doi. 10.3390/cancers10030062
- By:
- Publication type:
- Article
Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1214, doi. 10.1002/ajh.24887
- By:
- Publication type:
- Article
Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E623, doi. 10.1002/ajh.24865
- By:
- Publication type:
- Article
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bosutinib (BOS) vs Imatinib (IM) for Newly Diagnosed Chronic Myeloid Leukemia (CML): Initial Results from the BFORE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S316, doi. 10.1016/j.clml.2017.07.117
- By:
- Publication type:
- Article
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.
- Published in:
- Scientific Reports, 2017, p. 46823, doi. 10.1038/srep46823
- By:
- Publication type:
- Article
OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.
- Published in:
- Scientific Reports, 2017, p. 46290, doi. 10.1038/srep46290
- By:
- Publication type:
- Article
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1206, doi. 10.1002/ajh.24536
- By:
- Publication type:
- Article
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0293-y
- By:
- Publication type:
- Article
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 606, doi. 10.1002/ajh.24360
- By:
- Publication type:
- Article
Chronic myeloid leukemia: Second-line drugs of choice.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 1, p. 67, doi. 10.1002/ajh.24247
- By:
- Publication type:
- Article
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 97, doi. 10.1111/bjh.13801
- By:
- Publication type:
- Article
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 12, p. E227, doi. 10.1002/ajh.24210
- By:
- Publication type:
- Article